VC Fund Dossiers

360 Capital is one of Europe's most successful old-school VC shops that actually delivers results—their Preligens exit to Safran for €220M in 2024 and backing Exotec to become France's first industrial unicorn proves they know how to pick winners and get liquidity. Founded in 1997, they've survived multiple cycles and have the conviction to back deep tech when others chase software. Fausto Boni is a genuine operator with McKinsey pedigree who sits on boards and gets his hands dirty. The dual Paris-Milan setup gives them unique access to Southern European talent that coastal VCs miss. Their 71% seed to Series A conversion rate (92% including exits) is exceptional. Watch for their climate tech focus with the new €140M 360 LIFE II fund—they're betting big on energy transition when others just talk about it.

Here's the deal: Abingworth got acquired by Carlyle in 2022 for $2 billion AUM, which means you're now dealing with a PE-backed entity, not an independent VC. This changes the dynamic entirely. The good news? They have serious biotech chops - 179 companies invested, 70 IPOs, 46 M&As, and their portfolio companies have secured 26 FDA approvals in the last 9 years alone. That's not marketing fluff, that's real execution. Founders consistently praise them as 'very engaged partners' with 'deep knowledge of the industry' and 'extensive networks' - the CEO testimonials are unusually glowing for biotech VCs. They've innovated with VIPEs (Venture Investments in Public Equities) for undervalued <$200M market cap biotechs, plus clinical co-development - so they're not just writing checks, they're creating new funding mechanisms. The Carlyle backing gives them serious firepower, but it also means they're playing with institutional money that has different return expectations than traditional VC funds.

Accel Europe is the safe, prestigious choice - they've got the Spotify pedigree and write big checks, but they're not exactly scrappy anymore. They're excellent for founders who want a blue-chip logo on their cap table and have already proven some traction. The flip side: they can be slow to commit and their bar is high - expect multiple partner meetings and thorough due diligence. Post-investment, they're helpful with intros and strategic guidance but don't expect them to roll up their sleeves in the trenches. They're building a portfolio, not babysitting startups.

Act met Barry Napier "over a decade ago" and made "the largest seed investment we possibly could" - this is a fund that bets big early and doubles down on winners. They explicitly say "We have never been the loudest venture firm" and "don't want to add to the noise of VCs making it about them." Strong exit track record including SilverCloud Health (acquired by Amwell), Decawave (acquired by Qorvo), and 34 total portfolio exits. Their strategy is clear: "find the best company builders at the earliest stages and continue to back them again and again." This isn't a spray-and-pray fund - they're conviction-driven, founder-focused, and have the dry powder (€140M Fund VI) to support you through multiple rounds.

AENU is what happens when successful serial entrepreneurs get climate religion and build a fund around it. The Heilemann brothers sold DailyDeal to Google for €100M+, built Forto into a unicorn, then pivoted hard into impact investing with serious conviction. Their €170M fund closed above target in 2024, which tells you LPs are buying what they're selling. They've got the research chops (70% of deals come from internal "deep dives") and the operational experience founders actually want. But here's the thing - they're genuinely thesis-driven, not just climate-washing. They'll pass on "green" companies that don't meet their impact bar, including anything in the animal value chain or micromobility. The portfolio is performing (9 up-rounds already) and they're backing real climate tech, not feel-good sustainability theater.

Aglae is essentially Bernard Arnault's tech investment arm masquerading as a standalone VC - which is both their superpower and their Achilles heel. They have stupid money (LVMH backing means they can write big checks without blinking), phenomenal brand access through the luxury ecosystem, and a track record that includes some absolute bangers. But here's the catch: they're not really building a venture brand, they're executing family office investment strategy. The team is solid but small, and while Antoine brings decent deal flow, this isn't Sequoia-level pattern recognition. If you need growth capital and can benefit from luxury/premium brand connections, they're golden. If you want hands-on operational support or deep sector expertise, look elsewhere.

AlbionVC is the grown-up in the room of UK venture - they've been doing this since 1996 and it shows in their disciplined, thesis-driven approach. Their partners project an aura of patience and take a genuinely long-term view, with reputation and consistency carrying more weight than flashy deals. Founders consistently praise Ed Lascelles specifically - Tony Pepper from Egress called him "equally important" to their success alongside the team and tech, while Quantexa's CEO said they've been privileged to work with Ed and AlbionVC from the beginning. They actually stick around - Quantexa went from first investment in 2017 to a $175m Series F at $2.6bn valuation in 2025, with AlbionVC participating in every round. The downside? They're not going to move fast on trendy deals, and if you want VC theater or ego stroking, look elsewhere.

This is a classic Nordic operator-turned-investor story done right. Maria Ahr brings serious Goldman pedigree and operational chops to a fund that has genuine conviction in the Northern European tech ecosystem. Their track record speaks volumes - Trustly became a fintech giant, Mentimeter is a SaaS darling, and Acast went public. What makes them different is they actually stick around post-investment and take board seats across their portfolio. The Goldman connection gives them real credibility with later-stage investors when it's time to scale. However, they're not writing massive checks - typical investments seem to be in the $3-10M range, so don't expect them to lead your Series B.

Alliance is the rare Nordic VC that actually walks the walk on 'founder-friendly' instead of just talking about it. From your very first meeting, you're speaking directly with a partner — no junior associates wasting your time. Every partner has equal voting power and they make decisions by majority, but they value passionate conviction when a partner pounds the table for a deal. The sustainability angle isn't just marketing fluff — they genuinely believe it drives long-term value creation. Their exit rate is 19 percentage points higher than average VCs, which suggests they know how to pick and support winners. With offices across the Nordics and strong ties to Silicon Valley, they're well-positioned to help ambitious founders scale globally.

Amadeus is one of the rare VCs that actually walks the walk on deep tech—they've been at it since 1997 when most funds were still figuring out what the internet was. As one founder, whose startup ContactEngine was acquired by NICE Systems, put it, landing investment from Amadeus meant securing one of "the best VCs in our space." Hermann Hauser's track record speaks for itself (he basically created ARM), and Anne Glover has built this into a proper institution. They are active investors who commonly take board seats and provide strategic advice, recruitment support, and introductions to international networks and corporate partners. The firm prides itself on being supportive yet measured, understanding when to step back and let the founders steer their company. The exit track record is genuinely impressive—multiple billion-dollar outcomes across different cycles. But here's the rub: they're extremely technical and will grill you hard on IP and defensibility. founders should be prepared for rigorous technical due diligence from Amadeus's experienced partners, many of whom bring a deep scientific background themselves.

AP Ventures is the real deal in hydrogen VC — they've been in this space since 2013, way before hydrogen became trendy. AP Ventures was founded in July 2018 as an independent venture capital fund spun out of Anglo American Platinum's successful PGM Investment Programme. It launched with US $200 million in commitments, US $100 million each from cornerstone backers Anglo American Platinum and South Africa's Public Investment Corporation. Their deep technical expertise in electrochemistry and platinum group metals gives them a genuine edge in evaluating hydrogen tech that most generalist VCs lack. The partnership between Andrew Hinkly and Kevin Eggers brings serious industrial credibility — both come from Anglo American and understand how to scale hard tech in heavy industry. At our annual meeting earlier this month, we asked some of our portfolio companies to describe what working with AP Ventures has been like over the years. The fact they actively showcase founder testimonials suggests they're confident about their portfolio relationships. They're not just writing checks — they're leveraging their industrial network to help companies navigate the complex world of industrial customers and partnerships.

Armilar is the real deal - they've backed three unicorns (OutSystems, Feedzai, Sword Health) and have genuine deep-tech credibility spanning 25+ years. Their track record of generating returns is grounded on backing founders throughout their journey, not just writing checks. However, they work on 16 percentage points less than the average amount of lead investments, meaning they're selective but might not always lead your round. The fact they successfully raised €120M in 2025's brutal fundraising environment speaks volumes about LP confidence in their returns. The senior team has been working together for a decade with 60+ years of cumulative VC experience - this isn't a new fund with untested dynamics.

Atomico is the rare European fund that actually has the track record to back up their global ambition claims - Skype and Klarna exits speak for themselves. Niklas still takes meetings and brings genuine operator credibility that most European VCs lack. The downside? They can be slow to move and overly process-heavy compared to Valley funds. Also, despite the global positioning, they're still very Euro-centric in their network and thinking. If you're a European B2B founder who wants patient capital and someone who understands the regulatory complexity of scaling across European markets, they're solid. Just don't expect Silicon Valley-style speed or risk appetite.

Augmentum is the only publicly-listed fintech fund in Europe, which sounds impressive until you realize it's trading at a massive discount to NAV and just accepted a buyout offer from Verdane. NAV returned -3.5% but shareholders got hammered with -15.4% returns as the discount widened from 40% to 47%. The team has solid fintech pedigree - Tim and Richard built Flutter/Betfair before becoming investors - but being public creates pressure for quarterly performance that doesn't mesh well with early-stage venture investing. Portfolio companies do praise their "deep insight into fintech and scaling at pace" and describe them as a "go-to fund", suggesting they're genuinely helpful post-investment. The discount situation means they've been capital-constrained, which ironically might make them more selective and hands-on than flush VCs.

Axon is that rare breed - a publicly traded VC (BME: APG) with €685 million AUM that actually knows what they're doing. With 1 unicorn (Forto), 7 IPOs, and 11 acquisitions in their portfolio, they've got the track record to back up the hype. The dual consulting-investment model is either genius or a distraction - it gives them deep sector insights but might split focus. Francisco Velazquez landing on the EU Innovation Council board shows they have serious Brussels connections, which matters for regulatory-heavy sectors. They're heavy on Spain/Southern Europe but expanding globally, so perfect if you're a Spanish startup needing local expertise and international ambitions. The climate tech push feels authentic given their track record, not just trend-chasing.

Balderton is old-school European VC done right - they actually understand enterprise software and have the track record to prove it. Bernard's Business Objects pedigree opens doors that other London funds can't, and they're genuinely helpful with US expansion when you're ready. The downside? They can be slow to move and overly analytical - expect multiple partner meetings and extensive due diligence. They're also notorious for taking their time on follow-on rounds, which can be frustrating when you need quick bridge funding. That said, if you're building serious B2B software in Europe, they're one of the few funds that truly gets the category and won't try to turn you into a consumer play.

Balderton is old-school professional with genuine European market expertise — they actually understand regulatory environments and can help with international expansion beyond just writing checks. The partners have real operating experience and don't just play VC theater. However, they can be slow to move on hot deals and their brand doesn't carry the same weight in Silicon Valley if you need US expansion help. They're particularly strong on B2B SaaS metrics and will push you hard on unit economics, which is either great discipline or annoying micromanagement depending on your perspective. Portfolio founders generally speak highly of their post-investment support, especially for navigating European compliance and hiring.

BayBG is the reliable, unsexy choice for Bavarian B2B startups who want patient capital without fund timeline pressure. Their evergreen structure means no artificial exit deadlines, which is genuinely valuable in today's market. They've proven they can deliver exits (IDnow sold to Corsair Capital for $295M in March 2025 after backing them since 2015), but don't expect Silicon Valley-style hustle or global connections. They'll leverage their Bavarian corporate network for business development, which can be gold for enterprise startups. Marcus Gulder seems competent but low-profile - expect steady hands, not flashy thought leadership.

Bayern Kapital operates as a co-investor alongside private investors, adhering to the pari-passu principle, and typically holds minority stakes. We invest according to the pari-passu principle. In the case of a financing round, this means that all parties involved are treated equally and must invest the same amount of capital as Bayern Kapital. This is both their strength and potential limitation - they're patient, government-backed capital that won't push for quick exits, but they require private lead investors to move. With 3 unicorns (IQM, Quantum Systems, EGYM) and strong exits like MorphoSys, they clearly pick winners, but their bureaucratic structure means slower decisions than pure private funds. Their 8-10 year investment horizons and €700M+ AUM make them ideal for deep tech that needs patient capital, but expect more process and committees than your typical VC.

BGF isn't your typical Silicon Valley VC—it's basically the UK's answer to patient capital for grown-ups. BGF, established in 2011 as the Business Growth Fund, is a leading European mid-market private equity and investment firm that provides growth capital and scaleup support for small and mid-sized businesses in the UK and Ireland. It takes minority, non-controlling shareholdings in investee companies, and is acknowledged as the United Kingdom's most active growth equity investor. Entrepreneurs who've partnered with BGF often emphasize its balanced, relationship-driven approach. Royston Bayfield, founder of Bayfields Opticians, praised the fund as "hands-off, but a bit like family—always there if you need them," capturing the essence of BGF's supportive-but-not-intrusive ethos. They're bank-backed, which means they don't have the same exit pressure as traditional VCs, but also means they're not swinging for Silicon Valley-style moonshots. It makes initial investments between £3 million and £30 million, with the possibility for follow-on investments. We take a long-term view, with the ability to provide follow-on funding, and no fixed exit deadlines. We provide the growth capital you need, without taking control away from founders. Perfect if you want to build a real business without the "grow or die" hysteria.

Big Pi is the real deal in the Greek/diaspora space - they're not just tourist money but serious operators with legit exits under their belt (Accusonus to Meta for €70-100M). The team brings actual entrepreneurial chops: Marco built Upstream to €230M revenue, Nick was at Prime Ventures doing serious European deals, and Alex literally helped create the Python data science stack. They require portfolio companies to maintain substantial Greek operations, which is both a feature (cheap talent, government support) and potential bug (geographic constraint). Their "tech-first" mandate with IP requirements means they actually understand what defensible tech looks like, unlike funds that chase flashy B2C plays.

bmp Ventures is one of Germany's old guard VC firms with genuine track record - 25 years of venture capital experience, 11 funds, over 250 investments, 120 exits and more than 15 IPOs. That's not fluff, that's real dealflow. The Komoot exit to Bending Spoons in March 2025 was solid, and they've had other decent wins like Flightright. What's interesting is their heavy focus on cleantech/materials science - they're not chasing the latest AI hype but betting on industrial deep tech that actually solves problems. The fact that they manage government funds (Saxony-Anhalt) gives them patient capital but also bureaucratic constraints. Their average holding period is around 6 years - significantly longer for certain technologies, which is refreshing in a world of quick-flip VCs. Oliver Borrmann's been at this since 1997 and actually knows how to build companies, not just write checks.

They've delivered 20%+ annual returns since 2014 with portfolio value exceeding SEK 7B, but here's the reality: they rebranded from Bonnier Ventures to Bonnier Capital to signal they're moving upmarket to bigger, later-stage deals. The 'we're different because we're not a fund' pitch is real - they have patient capital from the 200-year-old Bonnier media empire. They lead fewer deals than average but exit more often, suggesting they're selective but effective. The Bonnier Group network can genuinely open doors, especially in media and Nordic markets. However, team is only 6 people for a portfolio this size, so don't expect hand-holding.

This is France's sovereign wealth fund playing VC - which means they have deeper pockets and longer patience than most, but also means they're not purely profit-driven. They offer unique convertible options that match private investment up to €250k with non-dilutive support, which founders love because it makes them more attractive to other investors. Their strategy is explicitly to create an 'entrepreneur friendly ecosystem' and develop France's VC industry to attract international money. The downside? Some French tech veterans like Ledger's co-founder argue that state backing has propped up fragile business models and created a 'perfusion economy' that masks underlying weaknesses. But founders consistently praise their operational involvement, strategic introductions, and commercial synergies that lead to 'decisive contracts.'

Breega is solid but not spectacular - they're the reliable European fund that won't wow you but probably won't disappoint either. Ben Marrel genuinely knows how to scale companies having done it himself, and they're actually helpful post-investment unlike some VCs who just show up to board meetings. The downside? They can be slow decision makers and their network outside Europe is limited. They also have a habit of leading rounds then getting diluted in later stages when bigger funds come in. Good for founders who want steady, experienced guidance and don't need flashy brand names on their cap table.

Bright Pixel is basically Sonae's corporate venture arm with €250M deployed across 60+ companies, which sounds impressive until you realize they're essentially a retail conglomerate trying to stay relevant in tech. The good news: they have four unicorns including Feedzai and Arctic Wolf, proving they can spot winners. The reality check: as a corporate VC, they're always going to prioritize strategic value over pure financial returns, which means potential acqui-hire pressure down the road. Their team seems genuinely knowledgeable about cybersecurity and retail tech, but founders should expect longer decision cycles and more stakeholder management than with pure-play VCs.

Bvalue is solid if you're a CEE founder or want access to that market, but they're not going to wow Silicon Valley with their network. They actually know their region well and have produced some legitimate exits, which puts them ahead of most regional European funds. The partners are former operators who get their hands dirty, but don't expect them to open doors in SF or lead your Series B. They're best as a local champion who can help you navigate Polish/CEE expansion and provide tactical support. The fund size means they can't write big checks, so plan accordingly for future rounds.

This is Spain's establishment VC - they're the corporate venture arm of CriteriaCaixa, which manages over €25 billion and is backed by la Caixa Foundation. They've been around since 2007 and have made 300+ investments, so they know what they're doing, but they're also exactly what you'd expect from a big Spanish bank's VC arm. The good news: they have serious capital staying power, they actually stick around for follow-on rounds, and they exit 20% more often than average. The reality check: they're not exactly known for being the fastest movers or most founder-friendly when it comes to terms. New CEO Jordi Ros comes from 20 years of traditional corporate finance, not startup-land.

CIC has genuinely unique deal flow through their exclusive Cambridge University relationship - this isn't marketing fluff, they literally have privileged access to the best IP coming out of one of the world's top research universities. Their track record speaks for itself: Bicycle Therapeutics IPO on NASDAQ, CMR Surgical unicorn, Gyroscope sold to Novartis for $1.5B, plus solid exits like Inivata ($390M) and PetMedix ($285M). Williamson brings serious credibility - 20 years US VC experience and co-chaired the UK government's university spinout review, so he knows the ecosystem inside out. Their Entrepreneur in Residence program is actually working - they're co-founding companies like Immutrin (just raised £65M from Frazier Life Sciences) by pairing seasoned operators with Cambridge academics. The downside? You're essentially betting on Cambridge staying relevant in deep tech, and they're very UK-focused if you want Silicon Valley-style growth.

Capricorn is the rare European VC that actually walks the walk on deep tech and sustainability—they've been doing cleantech since 2007, way before it was cool again. With 2 unicorns (Electric Hydrogen and Xanadu) in their portfolio and a track record spanning 26 years, they're not just another generalist fund pretending to understand hard science. Jos Peeters is a proper physics PhD who's been in the game for over three decades and built the European VC infrastructure we know today. The team genuinely gets technical due diligence, but here's the catch: they're very Belgian in their approach—methodical, relationship-focused, and not flashy. They invest mostly in Belgium (28 companies) and Netherlands (9 companies), so if you're not in their geographic sweet spot or willing to relocate there, you might find yourself on the outside looking in.

CDP is Italy's €4 billion sovereign wealth fund playing venture capitalist - which means you get the benefits of patient capital and government backing, but also all the bureaucracy that comes with it. They have an initial €1 billion to deploy and are making 40-50 investments per year, so they're not exactly selective. The real power here is Francesca Bria - she's the rare government appointee who actually gets technology and has street cred from transforming Barcelona's smart city approach. Under Resmini they grew from €230M to €4B AUM in 3 years, which is impressive scaling but raises questions about quality control. They're essentially the Italian government's attempt to bootstrap a venture ecosystem, so expect slower decision-making but also less pressure for quick exits since they're playing the long game for Italy's economic development.

Dawn is one of the more operationally-focused European funds that actually delivers on their promises to help with international expansion. Haakon's entrepreneurial credibility opens doors, and they're genuinely useful for European companies trying to crack the US market. They move fast when they want a deal and don't play games with term sheets. The downside? They can be pretty demanding post-investment and expect you to hit aggressive international growth targets. If you're not ready to scale globally quickly, they might not be the right fit.

Molten is the rare publicly-listed VC (FTSE 250) which gives you transparency but also means they're beholden to public market pressures that can create odd incentives. Their track record is solid - they've delivered strong exits like M-Files at 7.4x and Endomag at 3.9x MOIC, consistently hitting or beating their carrying values. They actually deliver on their value-add promises - portfolio companies genuinely praise their enterprise network connections and ability to accelerate sales cycles. The 'patient capital' positioning isn't just marketing - being public means they can hold positions longer than traditional fund cycles. Leadership transition is worth watching - new CEO Ben Wilkinson stepped up from CFO role when Martin Davis left, so jury's still out on strategic direction under new management.

Earlybird is one of Europe's genuine OG funds that's earned its stripes the hard way - they've been around since 1997 and have the exits to prove it. Their track record speaks volumes: early backer of UiPath (Europe's largest IPO ever), N26, and Aleph Alpha. What founders need to know is that this isn't just another check-writer - they genuinely get involved post-investment and have built serious operational expertise over 28 years. The recent restructuring shows they're not afraid to evolve and focus where they can add the most value. However, they're getting bigger and more institutionalized, which means longer decision cycles and more process than scrappy early-stage funds. They're also heavily Germanic in their approach - methodical, thorough, but sometimes slower to move than Silicon Valley-style funds.

Elaia is one of the rare European VCs that actually delivers on deep tech promises - they've built 3 unicorns (SandboxAQ, Shift Technology, Mirakl) and had legitimate exits like Criteo's $1.7B NASDAQ IPO and Teads' acquisition by Altice. Xavier Lazarus sits on boards and stays engaged post-investment, which founders consistently praise. The Lazard partnership (with minority stake and option to buy up to 100%) gives them serious growth capital firepower beyond typical VC constraints. However, one employee review noted they can lack operational character and become repetitive - potentially signaling they're better at picking winners than rolling up sleeves in the trenches. They're genuinely technical (math PhD founders) but watch for over-intellectualizing vs. practical market execution.

EQT Ventures is the real deal - they're not your typical suit-and-tie VC shop but actual operators who've been in the trenches. The team is made up of ex-founders and operators who know what it takes to build a company – the good, the bad, and everything in between. Their secret weapon is Motherbrain, a proprietary AI platform that monitors over 10 million companies and has guided over $100 million in portfolio investments. But here's what founders really need to know: they're serious about being hands-on post-investment and have the track record to prove it works. Their existing portfolio is performing in the top 5% of all funds of its vintage, and they're already returning money to investors - almost unheard of this early. The downside? They're popular, which means higher bars and more competition for deals.

Eurazeo is the French private equity heavyweight that's actually trying to be founder-friendly - and mostly succeeding. Many founders appreciate their authentic engagement without feeling displaced, with a partnership philosophy that resonates across stages. They've got serious scale (€39bn AUM) and real wins like Doctolib and Back Market, but here's the thing: some interview experiences reveal analysts who can be "borderline cocky" in a "not very pleasant" environment. The good news? 86% of employees would recommend working there, praising an "amazing culture" where "people are available to help." They're genuinely multi-stage (seed to Series C+) with deep sector expertise, but expect European-style formality and thorough due diligence processes that can drag on.

Felix has 11 unicorns in their portfolio including MUBI, Pigment, and Castore, with major exits like Deliveroo acquired by DoorDash for $3.86B in May 2025. This is the real deal — they called Peloton, Farfetch, and Goop when others thought they were crazy for focusing on 'lifestyle brands.' They famously missed Glossier and passed on Revolut because it wasn't in their core focus areas at the time, which shows both discipline and the cost of being hyper-focused. They're clear on what they want and act fast when they find it, preferring to build relationships early and long before any transaction. As a small focused firm, every investment matters, making them more aligned with founders. The trade-off: if you're not building a 'visual-first brand that shapes culture,' they're probably not your people.